|
WBP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60513832728293E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58699720032018E-11 |
| Normal-vs-Stage2 |
9.14389675088501E-11 |
| Normal-vs-Stage3 |
1.55431223447522E-15 |
| Normal-vs-Stage4 |
7.7715611723761E-15 |
| Stage1-vs-Stage2 |
1.977600E-01 |
| Stage1-vs-Stage3 |
4.629500E-02 |
| Stage1-vs-Stage4 |
1.403890E-03 |
| Stage2-vs-Stage3 |
8.620000E-01 |
| Stage2-vs-Stage4 |
2.896400E-01 |
| Stage3-vs-Stage4 |
2.696800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03306252441371E-12 |
| Normal-vs-AfricanAmerican |
1.31059999997074E-06 |
| Normal-vs-Asian |
5.15139997325775E-09 |
| Caucasian-vs-AfricanAmerican |
6.970200E-01 |
| Caucasian-vs-Asian |
5.035600E-01 |
| AfricanAmerican-vs-Asian |
9.256400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.71764857681956E-14 |
| Normal-vs-Female |
5.43032285804657E-12 |
| Male-vs-Female |
5.192200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.70400377036617E-11 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-15 |
| Normal-vs-Age(81-100Yrs) |
6.27530000000265E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.946000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.138430E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.696170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.798000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.624400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.964000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.068200E-02 |
| Classical-VS-Follicular |
4.892600E-01 |
| Classical-VS-Other |
7.684600E-01 |
| Classical-VS-Normal |
5.81440451341564E-11 |
| Tall-VS-Follicular |
2.458200E-01 |
| Tall-VS-Other |
5.441000E-01 |
| Tall-VS-Normal |
1.72190040004239E-11 |
| Follicular-VS-Other |
9.859000E-01 |
| Follicular-VS-Normal |
1.56680224350225E-11 |
| Other-VS-Normal |
2.579300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.11509690370326E-11 |
| N0-vs-N1 |
9.468200E-01 |
|
|
